Jan 05, 2017 7:30am EST Pieris Pharmaceuticals to Host Investor Call Today to Discuss Servier Collaboration
Jan 05, 2017 7:00am EST Pieris Pharmaceuticals and Servier Forge Strategic Immuno-oncology Co-development Alliance
Nov 09, 2016 5:50pm EST Pieris Pharmaceuticals Reports Financial Results and Provides Corporate Update for the Third Quarter Ended September 30, 2016
Nov 01, 2016 8:00am EDT Pieris Pharmaceuticals to Host Third Quarter 2016 Investor Call and Corporate Update on November 10, 2016
Oct 26, 2016 8:00am EDT Pieris Pharmaceuticals to Receive GLP Tox Milestone Payment in Daiichi Sankyo Collaboration
Sep 26, 2016 5:15pm EDT Pieris Pharmaceuticals Presents Positive Data for Its Lead Bispecific Drug Candidate, PRS-343, at the 2016 CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
Sep 22, 2016 8:00am EDT Pieris Pharmaceuticals Appoints Christopher Kiritsy to Its Board of Directors
